Navigation Links
Breast Cancer Recurrence Rates Appear Different When Radiation Used
Date:4/30/2011

By Kathleen Doheny
HealthDay Reporter

FRIDAY, April 29 (HealthDay News) -- Patients with early stage breast cancers are commonly treated with surgery or surgery plus radiation, and radiation is widely believed to cut local recurrence rates by about half.

Now, researchers report that they have found that surgery plus radiation does cut local recurrences, but appears to increase the risk of invasive breast cancers later.

"I don't want people to think radiation is bad," said study author Dr. Janie Weng Grumley, a fellow in breast oncology at the University of Southern California Keck School of Medicine. "We know there is less recurrence with radiation."

Grumley's team evaluated 1,014 patients with early breast cancer, known as ductal carcinoma in situ. Of these, 651 had surgery alone while 363 had surgery plus radiation.

The 10-year probability of any recurrence at the same site was 30 percent for the surgery group and 18 percent for the combination group. However, when cancer does return in those who get the combination treatment, her study showed the patterns are different.

"The patients who got radiation recurred a lot later than the patients who didn't," she said. The average time to the cancer recurring in the same site was 7.5 years for those who had radiation plus surgery and 4.4 years for those who had surgery only.

However, "surgery plus radiation had more invasive recurrence," she said. Thirty-seven percent of the surgery group had an invasive recurrence at the same site, but 57 percent of the combination group did, she said.

While 28 percent of the recurrences were in different quadrants of the breast for the combination patients -- essentially new cancers -- only 10 percent of the recurrences in surgery-only patients were in new quadrants.

The survival rate among the surgery group at 10 years was 99.7 percent, compared to 98.3 percent for the combination group, the study found.

The study leaves many questions unanswered. "Is the radiation causing more new cancers?" Grumley wondered.

The research also has several limitations: The average follow-up for the surgery group was six years, while the average follow-up for the combination group was a little over nine years. "One could say the follow-up is longer, and maybe we would find the same thing if we followed the surgery-only group," Grumley said.

The findings were slated to be presented Friday at the American Society of Breast Surgeons meeting, in Washington, D.C.

The finding should be considered very preliminary, said Dr. Otis Brawley, chief medical and scientific officer for the American Cancer Society and professor of oncology and epidemiology at the Emory University School of Medicine, in Atlanta.

"I would say you have to look at all abstracts from scientific meetings with a grain of salt," Brawley said. The research has not yet been exposed to rigorous review and critique by the researchers' colleagues, he said. If a study is the first of its kind, it must be replicated by others to confirm the finding.

Grumley said the message for now is that women should be aware of the different patterns found. "Really, the message should be we should monitor these patients beyond the [typical] five years," she added.

More information

To learn more about ductal carcinoma in situ, visit the U.S. National Institutes of Health.

SOURCES: Otis Brawley, M.D., chief medical and scientific officer, American Cancer Society, and professor, oncology and epidemiology, Emory University School of Medicine, Atlanta; Janie Weng Grumley, M.D., fellow, breast oncology, University of Southern California Keck School of Medicine; April 29, 2011, presentation, American Society of Breast Surgeons meeting, Washington, D.C.


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Paxil Blocks Tamoxifen, Lowers Survival Odds Against Breast Cancer
2. Low forms of cyclin E reduce breast cancer drugs effectiveness
3. Racial disparities persist in the diagnosis of advanced breast cancer and colon cancer in the U.S.
4. For Some Breast Cancer Patients, Shorter Radiation Works Well
5. Short-term radiation therapy successful on breast cancer
6. Few Women at High Risk for Breast Cancer Take Tamoxifen
7. Hormone May Prevent Aggressive Breast Cancer
8. MSU researcher linking breast cancer patients with alternative therapies
9. MRI May Not Add Value to Routine Breast Cancer Care
10. Breast Cancer Stats Differ Racially Despite Similar Mammogram Rates
11. Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Breast Cancer Recurrence Rates Appear Different When Radiation Used
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: